Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Prostatic Neoplasms × Radiotherapy × Clear all

Phase

Phase 2 49 Phase 3 41 Phase NA 25 Phase 1 13 Phase 1/2 8 Phase EARLY_PHASE1 1 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Leukemia 5 Esophageal Squamous Cell Carcinoma 5 Esophageal Neoplasms 5 Rectal Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Oropharyngeal Neoplasms 2 Oligodendroglioma 2 Nasopharyngeal Carcinoma 2 Myelodysplastic Syndromes 2 Lymphoma 2 Lung Neoplasms 2 Leukemia, T-Cell 2 Leukemia, Myeloid, Chronic-Phase 2 Leukemia, Myeloid, Acute 2 Leukemia, Myeloid, Accelerated Phase 2 Head and Neck Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma 2 Astrocytoma 2 Anemia, Refractory, with Excess of Blasts 2 Adenocarcinoma Of Esophagus 2 Stomach Neoplasms 1 Sezary Syndrome 1 Sarcoma, Synovial 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1 Radiation Injuries 1 Prostatic Neoplasms 1

Interventions

Docetaxel 7 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 4 Prednisone 4 Androgen Antagonists 4 Radiosurgery 3 gallium 68 PSMA-11 2 enzalutamide 2 bicalutamide 2 Zoledronic Acid 2 Triptorelin Pamoate 2 Mitoxantrone 2 Leuprolide 2 Goserelin 2 Celecoxib 2 Abiraterone Acetate 2 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2 satraplatin 1 maltodextrin 1 luprolide acetate gel depot 1 genistein combined polysaccharide 1 darolutamide 1 cabazitaxel 1 abiraterone 1 abemaciclib 1 Vitamin D 1 Therapeutics 1 Tea 1 Tacrolimus 1 Standard of Care 1 Soybean Proteins 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06282588 2024-02-28

THUNDER

Cancer Research Antwerp

Phase 2/3 Recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡